[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @ImmunityBio ImmunityBio, Inc. ImmunityBio, Inc. posts on X about prize the most. They currently have XXXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1242955282872848384/interactions)  - X Week XXXXX -XX% - X Month XXXXXX -XX% - X Months XXXXXX -XX% - X Year XXXXXXX +215% ### Mentions: X [#](/creator/twitter::1242955282872848384/posts_active)  - X Week X no change - X Month X -XX% - X Months XX -XX% - X Year XX +161% ### Followers: XXXXXX [#](/creator/twitter::1242955282872848384/followers)  - X Week XXXXXX +3.70% - X Month XXXXXX +6.50% - X Months XXXXXX +46% - X Year XXXXXX +341% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1242955282872848384/influencer_rank)  ### Social Influence [#](/creator/twitter::1242955282872848384/influence) --- **Social topic influence** [prize](/topic/prize) XXXX% **Top accounts mentioned or mentioned by** [@daviddin](/creator/undefined) [@bullishbruk](/creator/undefined) [@bambossie81](/creator/undefined) [@phoenxlights](/creator/undefined) [@akalikoo](/creator/undefined) [@oshea9_harry](/creator/undefined) [@deadbrokeinvest](/creator/undefined) [@hu72094742](/creator/undefined) [@oshin76](/creator/undefined) [@gretchmick](/creator/undefined) [@mk2foru](/creator/undefined) [@divinoreale](/creator/undefined) [@drpatsoonshiong](/creator/undefined) [@urotoday](/creator/undefined) [@rendom1_2](/creator/undefined) [@gibster630](/creator/undefined) [@cointastic](/creator/undefined) [@fairwater_17](/creator/undefined) [@trendwhizo](/creator/undefined) [@cryptohotep](/creator/undefined) ### Top Social Posts [#](/creator/twitter::1242955282872848384/posts) --- Top posts by engagements in the last XX hours "We've announced our new study called COVID-4.019-Long which further expands our clinical research efforts to assess ANKTIVAs potential beyond cancer or cancer-related diseases. Learn more about the study and its potential impact:" [X Link](https://x.com/ImmunityBio/status/1957786038698668359) [@ImmunityBio](/creator/x/ImmunityBio) 2025-08-19T12:45Z 12.2K followers, 18.4K engagements "The team at ImmunityBio extends our congratulations to Dr. Mary E. Brunkow Dr. Fred Ramsdell and Dr. Shimon Sakaguchi recipients of the 2025 Nobel Prize in Physiology or Medicine. This groundbreaking research on regulatory T cells has advanced the scientific understanding of immune tolerance providing the foundation for developing novel therapies targeting cancer and infectious diseases. We recognize and applaud their contributions to immunology which continue to inspire innovation. Read more:" [X Link](https://x.com/ImmunityBio/status/1975933479604154618) [@ImmunityBio](/creator/x/ImmunityBio) 2025-10-08T14:37Z 12.2K followers, 7176 engagements "Weve announced new paradigm-changing findings from the Phase X QUILT-3.055 study demonstrating ANKTIVA (nogapendekin alfa inbakicept-pmln) reverses lymphopenia (low natural killer and T cells) in patients with checkpoint inhibitor-resistant advanced non-small cell lung cancer (NSCLC) with this reversal resulting in significant prolonged median overall survival (mOS). Read more:" [X Link](https://x.com/ImmunityBio/status/1965043802164654466) [@ImmunityBio](/creator/x/ImmunityBio) 2025-09-08T13:25Z 12.2K followers, 12K engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@ImmunityBio ImmunityBio, Inc.
ImmunityBio, Inc. posts on X about prize the most. They currently have XXXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX -XX%
- X Month XXXXXX -XX%
- X Months XXXXXX -XX%
- X Year XXXXXXX +215%
Mentions: X #
- X Week X no change
- X Month X -XX%
- X Months XX -XX%
- X Year XX +161%
Followers: XXXXXX #
- X Week XXXXXX +3.70%
- X Month XXXXXX +6.50%
- X Months XXXXXX +46%
- X Year XXXXXX +341%
CreatorRank: XXXXXXXXX #
Social Influence #
Social topic influence prize XXXX%
Top accounts mentioned or mentioned by @daviddin @bullishbruk @bambossie81 @phoenxlights @akalikoo @oshea9_harry @deadbrokeinvest @hu72094742 @oshin76 @gretchmick @mk2foru @divinoreale @drpatsoonshiong @urotoday @rendom1_2 @gibster630 @cointastic @fairwater_17 @trendwhizo @cryptohotep
Top Social Posts #
Top posts by engagements in the last XX hours
"We've announced our new study called COVID-4.019-Long which further expands our clinical research efforts to assess ANKTIVAs potential beyond cancer or cancer-related diseases. Learn more about the study and its potential impact:"
X Link @ImmunityBio 2025-08-19T12:45Z 12.2K followers, 18.4K engagements
"The team at ImmunityBio extends our congratulations to Dr. Mary E. Brunkow Dr. Fred Ramsdell and Dr. Shimon Sakaguchi recipients of the 2025 Nobel Prize in Physiology or Medicine. This groundbreaking research on regulatory T cells has advanced the scientific understanding of immune tolerance providing the foundation for developing novel therapies targeting cancer and infectious diseases. We recognize and applaud their contributions to immunology which continue to inspire innovation. Read more:"
X Link @ImmunityBio 2025-10-08T14:37Z 12.2K followers, 7176 engagements
"Weve announced new paradigm-changing findings from the Phase X QUILT-3.055 study demonstrating ANKTIVA (nogapendekin alfa inbakicept-pmln) reverses lymphopenia (low natural killer and T cells) in patients with checkpoint inhibitor-resistant advanced non-small cell lung cancer (NSCLC) with this reversal resulting in significant prolonged median overall survival (mOS). Read more:"
X Link @ImmunityBio 2025-09-08T13:25Z 12.2K followers, 12K engagements